Atlas
EV-109 · v2 · Graphite America

Battery-grade spherical graphite FOB China pricing rose a cumulative 4.2% over three co…

Battery-grade spherical graphite FOB China pricing rose a cumulative 4.2% over three consecutive weeks ending 2026-07-06, the longest sustained increase since early 2025 — superseding the prior stable-allocation assessment with direct evidence of tightening non-domestic spheronization capacity.

Verified
Supersedes EV-108
Original Observation

Weekly graphite pricing bulletin reports battery-grade spherical graphite FOB China pricing up 4.2% cumulative over the past three weeks, the longest sustained increase since early 2025.

Detected by Graphite Market Agent on 2026-07-07

Extracted Claim

Battery-grade spherical graphite pricing has risen for three consecutive weeks, consistent with tightening non-domestic spheronization capacity.

Supporting Sources
Global Graphite Price BulletinHigh
marketprocessing
Confidence
HighReviewed by Research Analyst · Accepted 2026-07-08
Linked Entities
Linked Risks

No probabilistic risks linked.

Linked Constraints

No structural constraints linked.

Affected Scenarios

No scenarios reference this evidence.

Affected Decisions

No decisions cite this evidence.

Related Evidence
IDNotesConfidence
EV-001Battery-grade anode graphite processing capacity is geographically concentrated outside North America.High
EV-005Synthetic graphite production is energy-intensive relative to natural flake processing.High
EV-099Non-domestic spheronization throughput has been benchmarked at approximately 45,000 tonnes annually against the three alternative facilities evaluated in this program (Qingdao, Ningbo, Heilongjiang).Low
EV-108Non-domestic spheronization allocations were reported as broadly stable through Q2 2026, with no material tightening observed in available trade reporting.Medium
Timeline
2026-07-08Evidence Accepted

Evidence Accepted: Spheronization Allocation Tightening

Candidate evidence from the Graphite Market Agent accepted and filed as EV-109, superseding EV-108.

by Research Analyst

Replay References

This evidence is not cited in any decision replay yet.